Clinical Trial Update: Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating an oral microbiota–based therapeutic as a treatment option for Primary Sclerosing Cholangitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Snippet

Sponsor: University of Minnesota | Conditions: Primary Sclerosing Cholangitis | EARLY_Phase 1 | Status: RECRUITING